Episode Details

The latest FDA approval of FluMist, a nasal spray influenza vaccine that can now be self-administered or given by caregivers for individuals aged 2 to 49 years. A systematic review found that while skeletal muscle relaxants (SMRs) like baclofen and cyclobenzaprine offer short-term relief for certain pain conditions, their long-term effectiveness remains questionable. Another study evaluated 24-hour versus 15-hour oxygen therapy for severe hypoxemia, finding no added benefit from the longer regimen in reducing hospitalizations or deaths.